Results 121 to 130 of about 41,400 (225)

Modified Patent Hemostasis Strategy Based on the Platelet Counts for Transradial Access Chemoembolization in Patients with Hepatocellular Carcinoma: A Prospective Single-Center Study

Journal of Hepatocellular Carcinoma, 2023
Yin-Gen Luo, Xiao-Wu Zhang, Jiay-Wei Tsauo, Ying Li, Jin-Gui Li, Qing Peng, Ya-Wei Li, Wei Sun, He Zhao, Xiao Li Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of
Luo YG, Zhang XW, Tsauo JW, Li Y, Li JG, Peng Q, Li YW, Sun W, Zhao H, Li X   +9 more
doaj  

Guidance for Liver Rehabilitation in Chronic Liver Disease

Hepatology Research, Volume 56, Issue 3, Page 279-291, March 2026.
ABSTRACT In April 2023, the Japan Society of Hepatology published its official guidelines on liver rehabilitation for chronic liver disease. In this article, we summarize the current evidence on the role of liver rehabilitation in slowing the progression of chronic liver disease, particularly metabolic dysfunction‐associated steatotic liver disease ...
Shuji Terai, Hiroteru Kamimura, Yoichi Hiasa, Norio Akuta, Toru Ishikawa, Yuichiro Eguchi, Hironao Okubo, Takumi Kawaguchi, Miwa Kawanaka, Tatsuo Kanda, Masaaki Korenaga, Ryotaro Sakamori, Masahito Shimizu, Yoshio Sumida, Ryosuke Tateishi, Atsushi Tanaka, Naoki Tanaka, Yasuo Tanaka, Yuki Tahata, Masato Nakai, Tadashi Namisaki, Takashi Nishimura, Atsushi Hiraoka, Takeshi Matsui, Nami Mori, Akio Moriya, Tetsuo Takehara   +26 more
wiley   +1 more source

TIPS and HCC: friends or foes ? [PDF]

, 2016
Portal hypertension and hepatocellular carcinoma [HCC] are major complications of liver cirrhosis and may coexist in the same patient. Transjugular intrahepatic portosystemic shunt [TIPS] is an effective treatment for recurrent variceal bleeding
DE SANTIS, Adriano
core  

Efficacy and Safety of Supplemental Transarterial Chemoembolization Through Extrahepatic Collateral Arteries with Drug-eluting Beads: Treatment for Unresectable Hepatocellular Carcinoma

Drug Design, Development and Therapy, 2020
Sung-Hua Chiu,1 Ping-Ying Chang,2 Yu-Lueng Shih,3 Wen-Yen Huang,4 Kai-Hsiung Ko,1 Wei-Chou Chang,1 Guo-Shu Huang1 1Department of Radiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; 2Division of Hematology/Oncology ...
Chiu SH, Chang PY, Shih YL, Huang WY, Ko KH, Chang WC, Huang GS   +6 more
doaj  

Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: A systematic review [PDF]

, 2015
Background: Unresectable intrahepatic cholangiocarcinoma (ICC) portends a poor prognosis despite standard systemic treatments which confer minimal survival benefits and significant adverse effects.
Bester, L, Morris, D, Saxena, A, Shan, J, Shan, L, Yang, L.   +5 more
core   +1 more source

Fatores de Risco para o Desenvolvimento de Síndrome Pós-Quimioembolização após Quimioembolização Hepática para Tratamento de Hepatocarcinoma [PDF]

, 2018
Introduction: Hepatic transarterial chemoembolization is a widely used technique for the treatment of hepatocellular carcinoma. The most common complication of this procedure is postembolization syndrome.
Bilhim, T, Coimbra, E, Dutra, S, Lima, M, Veloso Gomes, F   +4 more
core  

Chemoembolization versus Radiotherapy for Single Hepatocellular Carcinomas of ≤3 cm Unsuitable for Image-Guided Tumor Ablation

Gut and Liver
Background/Aims: Local ablation therapy (LAT) is primarily recommended for solitary inoperable hepatocellular carcinomas (HCCs) of ≤3 cm in diameter. However, only two-thirds of uninodular small HCCs are suitable for LAT, and the second-best treatment ...
Jihye Lim, Euichang Kim, Sehee Kim, So Yeon Kim, Jin Hyoung Kim, Sang Min Yoon, Ju Hyun Shim   +6 more
doaj   +1 more source

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure. [PDF]

, 2019
Hepatitis B virus (HBV) is one of the most significant hepatocarcinogens. The ultimate goal of anti-HBV treatment is to prevent the development of hepatocellular carcinoma (HCC).
Coben, Robert M., Conn, Mitchell I., DiMarino, Anthony J., Hann, Hie-Won, Kroop, Howard, Martin, Aaron, Prieto, Jorge, Shinn, Brianna J.   +7 more
core   +1 more source

GEL-FORMING POLYMERS FOR EMBOLIZATION

Разработка и регистрация лекарственных средств, 2019
The review is about on polymers used as embol for vascular occlusion. Existing and developed means for embolization vascular were considered. Particular attention is paid to polymers and compositions on their basis, which it is capable of forming gel ...
S. A. Kedik, V. V. Suslov, A. P. Malkova, E. A. Shnyak, Y. M. Domnina   +4 more
doaj  

Intermediate hepatocellular carcinoma: current treatments and future perspectives [PDF]

, 2017
Current guidelines recommend transarterial chemoembolization (TACE) as the standard treatment of Barcelona-Clinic Liver Cancer (BCLC)-B patients. However, the long-term survival outcomes of patients managed with this technique do not appear fully ...
Bargellini, I., De Maria, N., De Simone, P., Dufour, J.-F, Goulis, I., Marinho, R. T.   +5 more
core